Research output per year
Research output per year
Fingerprint
Dive into the research topics where Giuseppe Fasolino is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
A phase 2 clinical trial of regorafenib in patients with advanced pretreated melanoma (RegoMel)
Dirven, I., Vounckx, M., Kessels, J. I. E., Vanlaer, N., von Kemp, B., Fasolino, G. & Neyns, B., 1 Jun 2024, In: Journal of Clinical Oncology. 42, 16, 9518.Research output: Contribution to journal › Meeting abstract (Journal)
Open Access -
Phase II Clinical Trial of Trametinib and Low-Dose Dabrafenib in Advanced, Previously Treated BRAFV600/NRASQ61 Wild-Type Melanoma (TraMel-WT)
Awada, G., Dirven, I., Schwarze, J. K., Tijtgat, J., Fasolino, G., Kockx, M. & Neyns, B., 15 Feb 2024, In: JCO precision oncology. 8, p. 1-10 10 p., PO.23.00493.Research output: Contribution to journal › Article › peer-review
Open AccessFile3 Citations (Scopus)29 Downloads (Pure) -
Assessment of Retinal Pigment Epithelium Alterations and Chorioretinal Vascular Network Analyses in Patients under Treatment with BRAF/MEK Inhibitor for Different Malignancies: A Pilot Study
Fasolino, G., Awada, G., Moschetta, L., Koulalis, J. S., Neyns, B., Verhelst, B., Van Elderen, P., Nelis, P., de Lichtbuer, P. C., Cools, W. & Ten Tusscher, M., 3 Feb 2023, In: Journal of clinical medicine. 12, 3, 10 p., 1214.Research output: Contribution to journal › Article › peer-review
Open AccessFile3 Citations (Scopus)34 Downloads (Pure) -
Retinal alterations associated with targeted cancer therapy
Fasolino, G., 2023, 130 p.Research output: Thesis › PhD Thesis
Open AccessFile226 Downloads (Pure) -
A lead-in safety study followed by a phase 2 clinical trial of dabrafenib, trametinib and hydroxychloroquine in advanced BRAFV600 mutant melanoma patients previously treated with BRAF-/MEK-inhibitors and immune checkpoint inhibitors
Awada, G., Schwarze, J. K., Tijtgat, J., Fasolino, G., Kruse, V. & Neyns, B., 1 Jun 2022, In: Melanoma Research. 32, 3, p. 183-191 9 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile14 Citations (Scopus)85 Downloads (Pure)
Activities
-
JCO precision oncology (Journal)
Giuseppe Fasolino (Editor)
14 Feb 2024Activity: Publication peer-review and editorial work › Publication peer-review
-
Diabetes Liga (External organisation)
Giuseppe Fasolino (Chair)
19 Apr 2024 → 19 Apr 2027Activity: Membership › Membership of external research organisation
-
Greek Vitreo-Retinal Society
Giuseppe Fasolino (Speaker)
1 Feb 2024Activity: Talk or presentation › Talk or presentation at a conference
-
Bilateral Macular Edema of unknown Origin during Pregnancy
Shervine Ameli (Speaker) & Giuseppe Fasolino (Speaker)
28 Nov 2024Activity: Talk or presentation › Talk or presentation at a conference
-
retina in progress
Giuseppe Fasolino (Speaker)
22 Jun 2023Activity: Talk or presentation › Talk or presentation at a conference
Thesis
-
Retinal alterations associated with targeted cancer therapy
Author: De Asmundis, C., Fasolino, G., Neyns, B. & Raus, P., 4 Dec 2023Student thesis: Master-after-master